- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06371690
The Effects of Using the Web-Based Double Eye Control Program on Medication Error
The Effects of Using the Web-Based Double Eye Control Program on Medication of High Risk Drugs in Pediatric Patients: The Effect of Web-Based Double Eye Control Program
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: In this study, it was aimed to examine the effect of using Web Based Double-Eye Control Program as a new decision support system in preventing errors and standardization in high-risk medications of pediatric nurses.
Methods: The study was carried out as a quasi-experimental study in the Pediatric Surgery Clinics of a university hospital using the "Pre-Test-Post-Test Model in a Single Group". The sample of the study consisted of all high-risk drugs (532 before the intervention, 538 after the intervention, a total of 1070 drug doses) administered by 24 nurses working in these clinics, taking part in medication and agreeing to take part in the study. Data were collected by the researcher using the Medication Observation Form. The Form was created based on the literature, and by making use of the "10 Correct Rules in Medication" and the Medication Skills Steps in the Double Eye Control Program. In the first step, medication error rates were determined through observation method. In the second step; the Web-Based Double-Eye Control Program, which is a standard drug dose calculation and medication program created by the researchers, was started to be implemented. Medication error rates were determined again through post-intervention observation method. Informed voluntary consent, ethics committee and hospital permissions were obtained for the implementation of the study.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Çi̇ğli̇
-
İzmir, Çi̇ğli̇, Turkey, 35620
- İzmir Katip Çelebi University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- The medications observed were to be in the high-risk drug group for children,
- Volunteering of nurses working in the clinic to participate in the research,
- Nurses working in the clinic should have had proper level of internet usage knowledge to use a web-based program.
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Medication errors during the application of high-risk drugs
Medication Errors During the Application of High-risk Drugs Before and After Using Web-Based Double-Eye Control Program
|
Web-Based Double-Eye Control Program, a web-based drug dose calculation program, is compatible with smartphones, tablets and computers.
On the interface of the website, the nurse is required to enter data such as the age, weight, medications and doses ordered by the physician of the patient.
When all these data are entered, the amount of medication that the nurse should give and whether the ordered dose is within the safe dose range for the patient are calculated by the program, so that the nurse can control her own calculations.
On the other interface of the website, there are medication instructions uploaded by the researchers.
With this interface, nurses access all pharmacological information about especially high-risk drugs (indications, contraindications, interacting drugs and fluids, fluids to be used for diluting, medication route, medication pace, etc.) and information that will enable the medication to be carried out in a standard way.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Error rates
Time Frame: Between January 2017 and September 2018
|
Medication errors during administration of high-risk drugs in pediatric patients
|
Between January 2017 and September 2018
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 17-11/37
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Main Heading (Descriptor) Terms
-
Hacettepe UniversityCompletedMain Heading (Descriptor) TermsTurkey
-
Istanbul Medipol University HospitalCompleted
-
Nanjing First Hospital, Nanjing Medical UniversityEnrolling by invitationMain Heading (Descriptor) TermsChina
Clinical Trials on Web-Based Double-Eye Control Program
-
Abant Izzet Baysal UniversityCompletedDepression | Psychological Distress | Pregnancy LossTurkey
-
University of BarcelonaUnknownObesity | OverweightSpain
-
Queen's University, BelfastAXA PPP HealthcareCompleted
-
University of North Carolina, Chapel HillRTI InternationalCompletedObesity | Overweight
-
Kessler FoundationRecruitingSpinal Cord Diseases | Spinal Cord InjuriesUnited States
-
Bilecik Seyh Edebali UniversitesiCompletedBreast Cancer | Chemotherapy-Induced Peripheral Neuropathy (CIPN)Turkey (Türkiye)
-
Gazi UniversityCompletedEvaluation of Effectiveness of the Web-Based Monitoring Program Given to Mothers of Premature BabiesGrowth | Infant Development | Maternal StressTurkey
-
Taipei Medical UniversityCompletedBreast Feeding | Self Efficacy | Feeding BehaviorIndonesia
-
McGill UniversityCanadian Institutes of Health Research (CIHR)CompletedIncreased Risk for Cardiovascular DiseaseCanada
-
Sunnybrook Health Sciences CentreNational Heart, Lung, and Blood Institute (NHLBI)UnknownRespiratory Distress Syndrome, AdultCanada